AC Immune ACIU
NASDAQ ACIU
$2.72 -0.09 (-3.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

AC Immune (ACIU) Return on Assets [ROA] (2016 - 2026)

Updated

AC Immune (ACIU) reported Return on Assets [ROA] of -29.71% for the quarter ended Jun 30, 2026, down 4.55 percentage points from -25.16% a year earlier but up 14.96 percentage points from the prior quarter.

Analysis

AC Immune (ACIU) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, AC Immune posted Return on Assets [ROA] of -37.89%, down 13.05 percentage points from the prior year.

  • Return on Assets [ROA] has a five-year change of -14.13 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Return on Assets [ROA] came in at -24.84% in the year ended Dec 31, 2024 (+5.47 pp), -30.31% in the year ended Dec 31, 2023 (+0.53 pp), -30.84% in the year ended Dec 31, 2022 (-1.29 pp) and -29.55% in the year ended Dec 31, 2021 (-5.79 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -44.67% in the quarter ended Mar 31, 2026 and a high of -16.39% in the quarter ended Sep 30, 2024.
  • Year over year, Return on Assets [ROA] has now declined in each of the last four quarters, with an average year-over-year change of -2.00 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was the quarter ended Sep 30, 2024 (a gain of 27.86 percentage points); the low point was the quarter ended Sep 30, 2025 (a drop of 21.70 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -44.67% (quarter ended Mar 31, 2026), -41.50% (quarter ended Dec 31, 2025) and -38.09% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 AC Immune 276.74 Mn 276.74 Mn - -29.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.71%
Mar 31, 2026 -44.67%
Dec 31, 2025 -41.50%
Sep 30, 2025 -38.09%
Jun 30, 2025 -25.16%
Mar 31, 2025 -23.28%
Dec 31, 2024 -21.01%
Sep 30, 2024 -16.39%
Jun 30, 2024 -29.99%
Mar 31, 2024 -31.01%
Dec 31, 2023 -32.69%
Sep 30, 2023 -44.25%
Jun 30, 2023 -39.88%
Mar 31, 2023 -38.73%
Dec 31, 2022 -36.60%
Sep 30, 2022 -35.56%
Jun 30, 2022 -33.83%
Mar 31, 2022 -30.35%
Dec 31, 2021 -31.61%
Sep 30, 2021 -34.58%
API Access

AC Immune Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEY